EDITORIAL
Published on 12 Apr 2022
Editorial: Targeted Immunotherapy for Cancer
doi 10.3389/fphar.2022.894681
- 1,059 views
- 2 citations
- Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- Targeted Immunotherapy for Cancer
Targeted Immunotherapy for Cancer
40k
Total Downloads
143k
Total Views and Downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 05 Nov 2021
Circulating Natural Autoantibodies to HER2-Derived Peptides Performed Antitumor Effects on Oral Squamous Cell Carcinoma
doi 10.3389/fphar.2021.693989
- 1,525 views
- 3 citations
SYSTEMATIC REVIEW
Published on 26 Aug 2021
Association Between Efficacy of Immune Checkpoint Inhibitors and Sex: An Updated Meta-Analysis on 21 Trials and 12,675 Non-Small Cell Lung Cancer Patients
doi 10.3389/fonc.2021.627016
- 1,791 views
- 9 citations
ORIGINAL RESEARCH
Published on 17 Aug 2021
Trends in the Research Into Immune Checkpoint Blockade by Anti-PD1/PDL1 Antibodies in Cancer Immunotherapy: A Bibliometric Study
doi 10.3389/fphar.2021.670900
- 4,325 views
- 9 citations
ORIGINAL RESEARCH
Published on 07 Jun 2021
Catenin Alpha-2 Mutation Changes the Immune Microenvironment in Lung Adenocarcinoma Patients Receiving Immune Checkpoint Inhibitors
doi 10.3389/fphar.2021.645862
- 3,305 views
- 6 citations
REVIEW
Published on 28 May 2021
Combination Strategies to Augment Immune Check Point Inhibitors Efficacy - Implications for Translational Research
doi 10.3389/fonc.2021.559161
- 7,379 views
- 45 citations
ORIGINAL RESEARCH
Published on 22 Mar 2021
Attitudes and Practices of Immune Checkpoint Inhibitors in Chinese Patients With Cancer: A National Cross-Sectional Survey
doi 10.3389/fphar.2021.583126
- 2,231 views
- 2 citations
REVIEW
Published on 05 Mar 2021
Medicinal Prospects of Antioxidants From Algal Sources in Cancer Therapy
doi 10.3389/fphar.2021.593116
- 18,084 views
- 68 citations
SYSTEMATIC REVIEW
Published on 25 Feb 2021
Results from a Meta-analysis of Combination of PD-1/PD-L1 and CTLA-4 Inhibitors in Malignant Cancer Patients: Does PD-L1 Matter?
doi 10.3389/fphar.2021.572845
- 3,276 views
- 8 citations
ORIGINAL RESEARCH
Published on 12 Feb 2021
Cardiotoxicity Induced by Immune Checkpoint Inhibitors: A Pharmacovigilance Study From 2014 to 2019 Based on FAERS
doi 10.3389/fphar.2021.616505
- 4,077 views
- 33 citations
ORIGINAL RESEARCH
Published on 13 Jan 2021
Dihydropyridine Calcium Channel Blockers Suppress the Transcription of PD-L1 by Inhibiting the Activation of STAT1
doi 10.3389/fphar.2020.539261
- 4,120 views
- 23 citations
REVIEW
Published on 11 Jan 2021
Next-Generation Immunotherapies to Improve Anticancer Immunity
doi 10.3389/fphar.2020.566401
- 7,941 views
- 10 citations
Published in
Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Impact
- 143kTopic views
- 100kArticle views
- 40kArticle downloads